Publicação
Intestinal mucosal alterations parallel central demyelination and remyelination: insights into the gut-brain axis in the cuprizone model of multiple sclerosis
| dc.contributor.author | Ferreira, Carolina | |
| dc.contributor.author | Carvalho, Filipa | |
| dc.contributor.author | Vieira, Pedro | |
| dc.contributor.author | Alves, André | |
| dc.contributor.author | Palavra, Filipe | |
| dc.contributor.author | Almeida, Jani | |
| dc.contributor.author | Alves, Vera | |
| dc.contributor.author | Coscueta, Ezequiel | |
| dc.contributor.author | Pereira, Patrícia Dias | |
| dc.contributor.author | Pintado, Manuela | |
| dc.contributor.author | Sá, Helena | |
| dc.contributor.author | Castelo-Branco, Miguel | |
| dc.contributor.author | Reis, Flávio | |
| dc.contributor.author | Viana, Sofia | |
| dc.date.accessioned | 2025-11-07T14:34:35Z | |
| dc.date.available | 2025-11-07T14:34:35Z | |
| dc.date.issued | 2025-10-28 | |
| dc.description.abstract | Background: The gut-brain axis has been increasingly recognized as a critical factor in Multiple Sclerosis (MS) pathophysiology. While its role in demyelination is well documented, gut-brain axis involvement during remyelination remains largely unexplored. Methods: Using the cuprizone (CPZ) model, which induces reversible demyelination and spontaneous remyelination upon toxin withdrawal, we investigated gut and brain changes during both disease stages in C57BL/6 mice. Animals were administered 0.2% cuprizone for 5 weeks to induce demyelination, followed by a 2-week recovery phase. Intestinal changes were evaluated through 1) gut microbiota profiling and metabolite production (short-chain fatty acids (SCFAs), indoxyl sulfate), 2) structural and barrier integrity via histology, mucus staining, and tight junction markers (ZO-1, occludin, claudin-5), 3) mucosal immunity through M1/M2 macrophage profiling and Th17/Treg ratios, and 4) expression of inflammatory and oxidative stress markers. Differences in brain demyelination/remyelination, gliosis and related molecular changes were determined using immunohistochemistry and real-time polymerase chain reaction (RT-PCR). Results: The demyelination peak was characterized by reduced abundance of SCFA-producing genus Akkermansia and Dubosiella, increased intestinal permeability at the level of the mucus layer and tight junction networks, and shifts in mucosal immunity toward a pro-inflammatory state characterized by M1 macrophages and Th17 cell expansion together with elevated levels of inflammatory cytokines (IL-17, IL-1?) and changes in oxidative stress-related enzymes (iNOS, HO-1, SOD1/2), all of which were partially reversed during the remyelination phase. Centrally, cuprizone-induced demyelination/remyelination and gliosis showed region-specific patterns. Neuroinflammation peaked during demyelination (TNF-?, IL-1?, IL-6, IL-17) and only partially resolved, suggesting that a balanced inflammatory response may aid remyelination. Conclusion: Our findings reveal that cuprizone-induced intestinal dysfunctions temporally parallel central nervous system (CNS) lesion dynamics, disclosing temporal coordination of both compartments and highlighting gut-brain axis impact on both disease stages. | eng |
| dc.identifier.citation | Ferreira, C., Carvalho, F., Vieira, P., & Alves, A. et al. (2025). Intestinal mucosal alterations parallel central demyelination and remyelination: insights into the gut-brain axis in the cuprizone model of multiple sclerosis. Frontiers in Immunology, 16, Article 1682183. https://doi.org/10.3389/fimmu.2025.1682183 | |
| dc.identifier.doi | 10.3389/fimmu.2025.1682183 | |
| dc.identifier.eid | 105021537631 | |
| dc.identifier.issn | 1664-3224 | |
| dc.identifier.other | 64b854ee-3cc9-4111-b73e-9a507e01cd17 | |
| dc.identifier.pmid | 41229423 | |
| dc.identifier.uri | http://hdl.handle.net/10400.14/55547 | |
| dc.identifier.wos | 001610607200001 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Cuprizone-induced demyelination | |
| dc.subject | Gliosis | |
| dc.subject | Gut-brain axis | |
| dc.subject | Gut microbiota | |
| dc.subject | Intestinal innate and adaptative immunity | |
| dc.subject | Multiple sclerosis | |
| dc.subject | Neuroinflammation | |
| dc.subject | Remyelination | |
| dc.title | Intestinal mucosal alterations parallel central demyelination and remyelination: insights into the gut-brain axis in the cuprizone model of multiple sclerosis | eng |
| dc.type | research article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | Frontiers in Immunology | |
| oaire.citation.volume | 16 | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |
Ficheiros
Principais
1 - 1 de 1
